NCT06635538 One-shot Ovarian Stimulation Protocol (One-shot)
| NCT ID | NCT06635538 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fundación Santiago Dexeus Font |
| Condition | Infertility, Female |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-10-31 |
| Primary Completion | 2025-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2024-10-31 with a primary completion date of 2025-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The current prospective observational pilot study aims to evaluate the endocrine profile of a single-injection protocol (single CFA + daily oral administration of CC).
Eligibility Criteria
Inclusion Criteria: Age \<= 40 AMH (Anti-Mullerian Hormone) 1.2-3.5 ng/ml or AFC 7-20 No family history of hereditary or chromosomal diseases Body mass index (BMI) 18 to 30 kg/m2
Contact & Investigator
Nikolaos P Polyzos, MD, PhD
PRINCIPAL INVESTIGATOR
Dexeus Fertility
Frequently Asked Questions
Who can join the NCT06635538 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 40 Years, studying Infertility, Female. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06635538 currently recruiting?
Yes, NCT06635538 is actively recruiting participants. Contact the research team at nikpol@dexeus.com for enrollment information.
Where is the NCT06635538 trial being conducted?
This trial is being conducted at Sabadell, Spain, Sant Cugat del Vallès, Spain, Barcelona, Spain.
Who is sponsoring the NCT06635538 clinical trial?
NCT06635538 is sponsored by Fundación Santiago Dexeus Font. The principal investigator is Nikolaos P Polyzos, MD, PhD at Dexeus Fertility. The trial plans to enroll 20 participants.